New USPTO rules confirm that AI can support the invention process, but only humans can legally claim inventorship under U.S. patent law.

Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to ...

As giant companies, especially in technology, propel the S&P 500 to new heights, a select group of mid-sized companies are ...

Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, ...

On this episode of Understanding IP Matters, Allison Gaul discusses the aggressive landscape of data acquisition by various AI entities.

But if X owner Elon Musk doesn’t see the value in the name, a startup called Operation Bluebird apparently does. The company ...

One of the difficulties of geoengineering is that in theory a single entity, like a startup company, could make decisions ...

Amgen Inc. is at least fairly valued, with improving balance sheet metrics and a robust growth pipeline offsetting looming ...

Susan Clayton, creator of WhitePaws RunMitts, still can’t believe her patented mittens are coming to Walmart stores by the ...

Mastick was six months pregnant when she got scheduled to appear on the show—in the nick of time before she was too far along ...